| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,064 |
1,712 |
$122K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,256 |
934 |
$34K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
151 |
147 |
$15K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,282 |
1,269 |
$12K |
| 96127 |
|
633 |
633 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
77 |
77 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
51 |
50 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
26 |
26 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
213 |
213 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
53 |
53 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
74 |
72 |
$879.94 |
| 90461 |
|
12 |
12 |
$452.64 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17 |
16 |
$200.77 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
40 |
39 |
$0.40 |